Corydon, Thomas J.

Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy

Askou, A. L., Alsing, S., Benckendorff, J. N. E., Holmgaard, A., Mikkelsen, J. G., Aagaard, L., Bek, T., & Corydon, T. J. (2019) · Molecular Therapy - Nucleic Acids

Retinal Diseases and TreatmentsRetinal Development and Disorders

Cited by 64

Targeted Knockout of the Vegfa Gene in the Retina by Subretinal Injection of RNP Complexes Containing Cas9 Protein and Modified SgRNAs

Holmgaard, A. B., Askou, A. L., Jensen, E. G., Alsing, S., Bak, R. O., Mikkelsen, J. G., & Corydon, T. J. (2021) · Molecular Therapy

CRISPR and Genetic EngineeringRNA Interference and Gene Delivery

Cited by 36

Brain volumetric alterations accompanied with loss of striatal medium-sized spiny neurons and cortical parvalbumin expressing interneurons in Brd1+/− mice

Qvist, P., Eskildsen, S. F., Hansen, B., Baragji, M., Ringgaard, S., Roovers, J., Paternoster, V., Molgaard, S., Corydon, T. J., Stødkilde-Jørgensen, H., et al. (2018) · Scientific Reports

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 23

Subretinal AAV delivery of RNAi-therapeutics targeting VEGFA reduces choroidal neovascularization in a large animal model

Haldrup, S. H., Fabian-Jessing, B. K., Jakobsen, T. S., Lindholm, A. B., Adsersen, R. L., Aagaard, L., Bek, T., Askou, A. L., & Corydon, T. J. (2024) · Molecular Therapy - Methods & Clinical Development

RNA Interference and Gene DeliveryRetinal Diseases and Treatments

Cited by 18